Studio di nuove strategie terapeutiche per l’Atassia di Friedreich
- 3 Anni 2011/2014
- 373.000€ Totale Fondi
Descrizione non disponibile
Pubblicazioni Scientifiche
- CELL REPORTS
E3 Ligase RNF126 Directly Ubiquitinates Frataxin, Promoting Its Degradation: Identification of a Potential Therapeutic Target for Friedreich Ataxia
- EXPERIMENTAL GERONTOLOGY
Autophagy induction extends lifespan and reduces lipid content in response to frataxin silencing in C. elegans
- FRONTIERS IN MOLECULAR NEUROSCIENCE
Analyzing the Effects of a G137V Mutation in the FXN Gene
- HUMAN MOLECULAR GENETICS
Interferon gamma upregulates frataxin and corrects the functional deficits in a Friedreich ataxia model
- HUMAN MOLECULAR GENETICS
Src inhibitors modulate frataxin protein levels
- MOVEMENT DISORDERS
Drug repositioning screening identifies etravirine as a potential therapeutic for friedreich's ataxia
- NEUROBIOLOGY OF DISEASE
Highly specific ubiquitin-competing molecules effectively promote frataxin accumulation and partially rescue the aconitase defect in Friedreich ataxia cells